Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C4H9NO2 |
| Molecular Weight | 103.1198 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](CN)C(O)=O
InChI
InChIKey=QCHPKSFMDHPSNR-GSVOUGTGSA-N
InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m1/s1
| Molecular Formula | C4H9NO2 |
| Molecular Weight | 103.1198 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 15:41:47 GMT 2023
by
admin
on
Sat Dec 16 15:41:47 GMT 2023
|
| Record UNII |
EE05FIB1LR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2140-95-6
Created by
admin on Sat Dec 16 15:41:48 GMT 2023 , Edited by admin on Sat Dec 16 15:41:48 GMT 2023
|
PRIMARY | |||
|
16320
Created by
admin on Sat Dec 16 15:41:48 GMT 2023 , Edited by admin on Sat Dec 16 15:41:48 GMT 2023
|
PRIMARY | |||
|
DTXSID70420079
Created by
admin on Sat Dec 16 15:41:48 GMT 2023 , Edited by admin on Sat Dec 16 15:41:48 GMT 2023
|
PRIMARY | |||
|
5459822
Created by
admin on Sat Dec 16 15:41:48 GMT 2023 , Edited by admin on Sat Dec 16 15:41:48 GMT 2023
|
PRIMARY | |||
|
EE05FIB1LR
Created by
admin on Sat Dec 16 15:41:48 GMT 2023 , Edited by admin on Sat Dec 16 15:41:48 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |
BOTH ISOMERS MAY BE ACTIVE
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
BAIBA induces energy expenditure in adipocytes and distal fat tissues, and β-oxidation of hepatic fatty acids in part via activation of peroxisome proliferators-activated receptor α (PPARα) [33]. Notably, in humans, plasma BAIBA concentrations increase with exercise and are inversely associated with metabolic risk factors.
|
